Cargando…

The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine

Many benign diseases, so called because they are not a direct cause of death, nevertheless cause significant damage to the health of patients due to the associated pain, reduced functionality, increased disability and the negative impact they have on quality of life, which, together with the limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero, Angel, Alvarez, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132200/
https://www.ncbi.nlm.nih.gov/pubmed/37122917
http://dx.doi.org/10.5603/RPOR.a2023.0001
_version_ 1785031344703668224
author Montero, Angel
Alvarez, Beatriz
author_facet Montero, Angel
Alvarez, Beatriz
author_sort Montero, Angel
collection PubMed
description Many benign diseases, so called because they are not a direct cause of death, nevertheless cause significant damage to the health of patients due to the associated pain, reduced functionality, increased disability and the negative impact they have on quality of life, which, together with the limited efficacy of many of the available treatments, make their management a challenge for every specialist. Radiotherapy, which has demonstrated its efficacy not only against cancer but also in many non-tumorous diseases, appears as a therapeutic option that deserves to be taken into account. However, there is still much resistance to considering the use of radiotherapy as a valid and acceptable alternative. The 5Rs to darken summarize the doubts and contradictions many specialists face to accept radiotherapy in non-neoplastic diseases. However, other 5Rs (to shine) can be argued to claim for the safety, reliability, and usefulness of radiation treatment for benign disease and as radiotherapy specialists we have to help the evidence shine and the darkness disappear.
format Online
Article
Text
id pubmed-10132200
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-101322002023-04-27 The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine Montero, Angel Alvarez, Beatriz Rep Pract Oncol Radiother Review Article Many benign diseases, so called because they are not a direct cause of death, nevertheless cause significant damage to the health of patients due to the associated pain, reduced functionality, increased disability and the negative impact they have on quality of life, which, together with the limited efficacy of many of the available treatments, make their management a challenge for every specialist. Radiotherapy, which has demonstrated its efficacy not only against cancer but also in many non-tumorous diseases, appears as a therapeutic option that deserves to be taken into account. However, there is still much resistance to considering the use of radiotherapy as a valid and acceptable alternative. The 5Rs to darken summarize the doubts and contradictions many specialists face to accept radiotherapy in non-neoplastic diseases. However, other 5Rs (to shine) can be argued to claim for the safety, reliability, and usefulness of radiation treatment for benign disease and as radiotherapy specialists we have to help the evidence shine and the darkness disappear. Via Medica 2023-04-06 /pmc/articles/PMC10132200/ /pubmed/37122917 http://dx.doi.org/10.5603/RPOR.a2023.0001 Text en © 2023 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
spellingShingle Review Article
Montero, Angel
Alvarez, Beatriz
The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine
title The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine
title_full The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine
title_fullStr The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine
title_full_unstemmed The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine
title_short The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine
title_sort 5rs dilemma of radiotherapy for non-malignant diseases: 5rs to darken or 5rs to shine
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132200/
https://www.ncbi.nlm.nih.gov/pubmed/37122917
http://dx.doi.org/10.5603/RPOR.a2023.0001
work_keys_str_mv AT monteroangel the5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine
AT alvarezbeatriz the5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine
AT monteroangel 5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine
AT alvarezbeatriz 5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine